Spots Global Cancer Trial Database for Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab
Official Title: Retrospective Study Assessing Molecular Features Predicting Response or Resistance to Cetuximab Therapy in Metastatic Colorectal Cancer Patients
Study ID: NCT00491140
Conditions
Interventions
Study Description
Brief Summary: The primary objective is to identify molecular features predicting response or resistance to cetuximab
Detailed Description: Secondary objective is to investigate association of genomic status of EGFR and HER-2 genes with clinical outcome, including objective response, time to progression and survival
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Istituto Clinico Humanitas, Rozzano, Milan, Italy
Contact Details
Name: Armando Santoro, MD
Affiliation: Istituto Clinico Humanitas
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
